Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial

Clicks: 473
ID: 267950
1970
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #13 of 149 articles by views in JAMA

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 149 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
In our study of outpatient treatment of acute uncomplicated pyelonephritis in women, a 7-day ciprofloxacin regimen was associated with greater bacteriologic and clinical cure rates than a 14-day trimethoprim-sulfamethoxazole regimen, especially in patients infected with trimethoprim-sulfamethoxazole …
Reference Key
da1970jamacomparison Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Talan DA;Stamm WE;Hooton TM;Moran GJ;Burke T;Iravani A;Reuning-Scherer J;Church DA;;
Journal JAMA
Year 1970
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/10735395
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't adult female middle aged Drug Administration Schedule Comparative Study Clinical Trial Randomized Controlled Trial Double-Blind Method Multicenter Study drug resistance acute disease microbial anti-infective agents trimethoprim ciprofloxacin / economics health care costs anti-infective agents / therapeutic use* anti-infective agents / administration & dosage sulfamethoxazole drug combination / therapeutic use* ciprofloxacin / administration & dosage w e stamm urinary / therapeutic use* sulfamethoxazole drug combination / administration & dosage ciprofloxacin / therapeutic use* pmid:10735395 doi:10.1001/jama.283.12.1583 d a talan d a church anti-infective agents / economics urinary / administration & dosage urinary / economics pyelonephritis / drug therapy* pyelonephritis / economics pyelonephritis / microbiology sulfamethoxazole drug combination / economics

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.